JPWO2023056243A5 - - Google Patents
Info
- Publication number
- JPWO2023056243A5 JPWO2023056243A5 JP2024519268A JP2024519268A JPWO2023056243A5 JP WO2023056243 A5 JPWO2023056243 A5 JP WO2023056243A5 JP 2024519268 A JP2024519268 A JP 2024519268A JP 2024519268 A JP2024519268 A JP 2024519268A JP WO2023056243 A5 JPWO2023056243 A5 JP WO2023056243A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- binding site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163250092P | 2021-09-29 | 2021-09-29 | |
| US63/250,092 | 2021-09-29 | ||
| PCT/US2022/077068 WO2023056243A1 (en) | 2021-09-29 | 2022-09-27 | Antibodies targeting baff-r and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024537772A JP2024537772A (ja) | 2024-10-16 |
| JPWO2023056243A5 true JPWO2023056243A5 (https=) | 2025-10-07 |
| JP2024537772A5 JP2024537772A5 (https=) | 2025-10-07 |
Family
ID=85780903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519268A Pending JP2024537772A (ja) | 2021-09-29 | 2022-09-27 | Ｂａｆｆ－ｒを標的化する抗体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240228645A1 (https=) |
| EP (1) | EP4408891A4 (https=) |
| JP (1) | JP2024537772A (https=) |
| KR (1) | KR20240069787A (https=) |
| CN (1) | CN118317975A (https=) |
| AR (1) | AR127163A1 (https=) |
| AU (1) | AU2022354054A1 (https=) |
| CA (1) | CA3233246A1 (https=) |
| IL (1) | IL311600A (https=) |
| MX (1) | MX2024003913A (https=) |
| TW (1) | TW202330604A (https=) |
| WO (1) | WO2023056243A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202091887A1 (ru) | 2018-02-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Комбинированная терапия рака с применением мультиспецифических связывающих белков, которые активируют естественные клетки-киллеры |
| DK3749346T3 (da) | 2018-02-08 | 2024-09-09 | Dragonfly Therapeutics Inc | Antistof variable domænekombinationer rettet mod nkg2d-receptoren |
| WO2020033630A1 (en) | 2018-08-08 | 2020-02-13 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use |
| EA202091888A1 (ru) | 2018-08-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Вариабельные домены антител, нацеленные на рецептор nkg2d |
| US12378318B2 (en) | 2018-08-08 | 2025-08-05 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and a tumor-associated antigen |
| JP2024508894A (ja) | 2021-03-03 | 2024-02-28 | ドラゴンフライ セラピューティクス， インコーポレイテッド | Ｎｋｇ２ｄ、ｃｄ１６、及び腫瘍関連抗原に結合する多特異性結合タンパク質を使用して癌を治療する方法 |
| WO2025067496A1 (zh) * | 2023-09-28 | 2025-04-03 | 南京驯鹿生物技术股份有限公司 | 靶向baff-r的全人源抗体、car-t细胞及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0518994A2 (pt) * | 2004-12-31 | 2008-12-02 | Biogen Idec Inc | anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas |
| WO2009120922A2 (en) * | 2008-03-27 | 2009-10-01 | Zymogenetics, Inc. | Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| KR101314369B1 (ko) * | 2008-07-17 | 2013-10-10 | 노파르티스 아게 | 치료학적 항체에 대한 조성물 및 사용 방법 |
| JP2012513195A (ja) * | 2008-12-23 | 2012-06-14 | アストラゼネカ アクチボラグ | α５β１に向けられた標的化結合剤およびその使用 |
| US9216219B2 (en) * | 2012-06-12 | 2015-12-22 | Novartis Ag | Anti-BAFFR antibody formulation |
| CN116041514A (zh) * | 2016-06-06 | 2023-05-02 | 希望之城 | Baff-r抗体及其用途 |
| WO2021163989A1 (en) * | 2020-02-21 | 2021-08-26 | Yinnuolai Biotech Ltd. | Anti-baff receptor antibodies and uses thereof |
-
2022
- 2022-09-27 JP JP2024519268A patent/JP2024537772A/ja active Pending
- 2022-09-27 KR KR1020247013643A patent/KR20240069787A/ko active Pending
- 2022-09-27 AU AU2022354054A patent/AU2022354054A1/en active Pending
- 2022-09-27 AR ARP220102598A patent/AR127163A1/es unknown
- 2022-09-27 CN CN202280064772.4A patent/CN118317975A/zh active Pending
- 2022-09-27 EP EP22877491.5A patent/EP4408891A4/en active Pending
- 2022-09-27 IL IL311600A patent/IL311600A/en unknown
- 2022-09-27 WO PCT/US2022/077068 patent/WO2023056243A1/en not_active Ceased
- 2022-09-27 TW TW111136545A patent/TW202330604A/zh unknown
- 2022-09-27 CA CA3233246A patent/CA3233246A1/en active Pending
- 2022-09-27 MX MX2024003913A patent/MX2024003913A/es unknown
-
2024
- 2024-03-28 US US18/620,375 patent/US20240228645A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL311600A (en) | Antibodies targeting BAFF-R and their use | |
| US11591401B2 (en) | Anti-CD28 compositions | |
| IL317912A (en) | A combined chimeric antigen receptor targeting CD19 and CD20 and its applications | |
| JP2021526844A5 (https=) | ||
| JP2025061672A (ja) | Ｅｎｐｐ３およびｃｄ３に結合するヘテロ二量体抗体 | |
| CA3091764A1 (en) | Antibody variable domains targeting cd33, and use thereof | |
| CA3020864A1 (en) | Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof | |
| JP7503642B2 (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 | |
| JPWO2020228825A5 (https=) | ||
| US20250043001A1 (en) | Anti-cd28 compositions | |
| JPWO2019245991A5 (https=) | ||
| JPWO2021076554A5 (https=) | ||
| JPWO2023056243A5 (https=) | ||
| JP2021524451A (ja) | 最適化済みｇｐ４１結合分子及びその使用 | |
| JPWO2022081516A5 (https=) | ||
| EP4469478A1 (en) | Bispecific molecule with tunable affinity to a targetted antigen | |
| JPWO2021226163A5 (https=) | ||
| US20250084186A1 (en) | Anti-cd28 x anti-enpp3 antibodies | |
| JPWO2023056252A5 (https=) | ||
| JPWO2023274384A5 (https=) | ||
| JPWO2022012681A5 (https=) | ||
| JP7854121B2 (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 | |
| JPWO2022097061A5 (https=) | ||
| JPWO2023030272A5 (https=) | ||
| HK40073541A (en) | Miniature guidance and navigation control (minignc) antibody-like proteins and methods of making and using thereof |